Home Blog Page 56

Blog

Pharma Marketing Blog

Most popular

Not Lost in Translation: Barcelona, Catalonia, and Global Pharmaguy

Pharma Guy - September 17, 2013

Pfizer’s Slumdog Sales Rep

Pharma Guy - July 8, 2009

Gamification’s Brave New World Circa 1984: Operation Frog

Pharma Guy - July 14, 2012

DTC Ad Spend is Back Stronger Than Ever, Baby!

Pharma Guy - March 23, 2015

Awards: POE vs. MM&M. I Pick Winners!

Pharma Guy - October 25, 2007

Viagra Boxers: An Example of Proto-Nostalgia tchotchke

Pharma Guy - April 14, 2009

NAMI’s Pharma Funders – Serial Off-label Promoter Astrazeneca Tops the List

Pharma Guy - April 29, 2010

FDA Warns GSK About Enlarged Avodart Ad Imagery

Pharma Guy - February 25, 2009

Will Novo Air a Super Bowl Commercial?

Pharma Guy - January 25, 2013

Guidelines for Gifts to Patients

Pharma Guy - May 7, 2007

1...555657...240 Page 56 of 240

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Researcher analyzing genetic data for an ultra-rare disease alongside physicians, DNA imagery, and patient silhouettes representing rare disease awareness and patient identification.

How Do You Market a Disease That Doesn’t Officially Exist?

August 6, 2026

Healthcare professional reviewing a plain-language clinical trial summary with a patient, illustrating how transparent communication strengthens trust, patient engagement, and pharmaceutical marketing.

The Plain-Language Revolution: How Compliance Is Becoming a Marketing Advantage

August 5, 2026

Healthcare professional reviewing a personalized medication dosing plan, illustrating flexible dosing strategies that support patient persistence and individualized treatment.

Could Flexible Dosing Become Pharma’s Next Competitive Advantage?

August 4, 2026